Adimab Team Accuses Prominent MIT Investigator Of Ripping Off Antibodies, Presenting Them As His Own

May 22, 2019

May 22, 2019 | In an opinion paper published yesterday, John Carroll at Endpoints News speaks with Adimab chief Tillman Gerngross and MIT investigator Ram Sasisekharan about Gerngross's recent allegations against Sasisekharan, claiming he has been ripping off the work of others in the antibody field and passing it off as his own design done in silico. Gerngross and other Adimab colleagues published their analysis of Sasisekharan's work in a paper for MABS (DOI: Sasisekharan has denied the accusations. Endpoints News